Disturbances in endothelial cell (EC) barrier regulation is a hallmark of lung inflammation, angiogenesis and cancer, and is critically dependent upon rearrangements in the cytoskeleton (microfilaments and microtubules). We have previously shown the involvement of microfilaments in actomyosin-driven contraction in specific models of lung EC permeability. For example, edemagenic agents such as thrombin increase the level of phosphorylation of myosin """"""""regulatory"""""""" light chain (MLC20), which is tightly linked to stress fiber formation, gap formation and barrier dysfunction. In contrast, cAMP elevation has a barrier protective effect and significantly attenuates thrombin-induced MLC phosphorylation and barrier dysfunction. Although information is limited as how to changes in microtubule network regulate EC contractility, careful temporal analysis of the MLC phosphorylation status in cultured EC reveals that disruption of the cellular microtubule structure with the clinically relevant agents such as vinblastine significantly increases MLC phosphorylation, decreases electrical resistance of EC monolayer and increases transendothelial neutrophil migration reflecting EC barrier dysfunction. Stabilization of microtubule structure by paclitaxel completely abolishes these effects and significantly attenuates thrombin-induced EC stress fiber formation. In addition, microtubule disruption activates MAP kinase (p38 and ERKs) pathway in endothelium, which also potentially can be involved in MLC-independent EC contractility via phosphorylation of key cytoskeletal proteins, like caldesmon and HSP-27. In this proposal, we will explore the role of MLC-dependent and MLC-independent mechanisms in the regulation of EC contraction and barrier dysfunction, induced by microtubule disruption in both macro- and microvascular endothelium. In SA 1 we will identify mechanisms leading of microtubule-mediated increases in EC MLC phosphorylation by examining how MLC-specific kinase and phosphatase activities are affected by microtubule alterations. In SA 2 we will identify MLC-independent pathways involved in microtubule-mediated EC contractility and barrier dysfunction and examine the effect of MAPK activities on cytoskeletal protein phosphorylation, cytoskeletal rearrangement and barrier function. In SA 3 we will examine the ole of cAMP-mediated barrier protection on EC barrier failure, induced by microtubule disruption. These studies will provide an understanding of novel signaling pathways involved in lung EC barrier regulation and promise new directions and targets for treatment of lung disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL067307-04
Application #
6728225
Study Section
Special Emphasis Panel (ZRG1-RAP (03))
Program Officer
Denholm, Elizabeth M
Project Start
2001-04-01
Project End
2005-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
4
Fiscal Year
2004
Total Cost
$163,500
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Alieva, Irina B; Zemskov, Evgeny A; Smurova, Ksenija M et al. (2013) The leading role of microtubules in endothelial barrier dysfunction: disassembly of peripheral microtubules leaves behind the cytoskeletal reorganization. J Cell Biochem 114:2258-72
Kása, Anita; Czikora, István; Verin, Alexander D et al. (2013) Protein phosphatase 2A activity is required for functional adherent junctions in endothelial cells. Microvasc Res 89:86-94
Kim, Kyung-mi; Adyshev, Djanybek M; Kása, Anita et al. (2013) Putative protein partners for the human CPI-17 protein revealed by bacterial two-hybrid screening. Microvasc Res 88:19-24
Kim, Kyung-Mi; Csortos, Csilla; Czikora, Istvan et al. (2012) Molecular characterization of myosin phosphatase in endothelium. J Cell Physiol 227:1701-8
Gorshkov, Boris A; Zemskova, Marina A; Verin, Alexander D et al. (2012) Taxol alleviates 2-methoxyestradiol-induced endothelial permeability. Vascul Pharmacol 56:56-63
Lucas, Rudolf; Yang, Guang; Gorshkov, Boris A et al. (2012) Protein kinase C-? and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability. Am J Respir Cell Mol Biol 47:445-53
Antonov, Alexander S; Antonova, Galina N; Fujii, Makiko et al. (2012) Regulation of endothelial barrier function by TGF-ýý type I receptor ALK5: potential role of contractile mechanisms and heat shock protein 90. J Cell Physiol 227:759-71
Poirier, Christophe; Berdyshev, Evgeny V; Dimitropoulou, Christiana et al. (2012) Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema. Mamm Genome 23:758-63
Poirier, Christophe; Gorshkov, Boris A; Zemskova, Marina A et al. (2011) TIMAP protects endothelial barrier from LPS-induced vascular leakage and is down-regulated by LPS. Respir Physiol Neurobiol 179:334-7
Bogatcheva, Natalia V; Zemskova, Marina A; Gorshkov, Boris A et al. (2011) Ezrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperpermeability. Am J Respir Cell Mol Biol 45:1185-94

Showing the most recent 10 out of 59 publications